What are the risks of investing in ALDX?
A
What are the risks of investing in ALDX?
🦉
Aldeyra Therapeutics, Inc. (ALDX)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOTodd C. Brady
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry...
Key Executives
| Name | Title |
|---|---|
| Adam Lazorchak | Director of Translational Sciences & Non-Clinical Development |
| David Burke | Head of Investor Relations |
| Laura Nichols | Operations Manager |
| Michael Alfieri | Head of Finance and Principal Financial & Accounting Officer |
| Stephen G. Machatha | Chief Development Officer |
| Todd C. Brady | Chief Executive Officer, President & Director |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A